The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 24, 2011
Filed:
Mar. 09, 2006
David R. Brittelli, Branford, CT (US);
Kevin S. Currie, North Branford, CT (US);
James W. Darrow, Wallingford, CT (US);
Jeffrey E. Kropf, Branford, CT (US);
Seung H. Lee, Branford, CT (US);
Steven L. Gallion, Wallingford, CT (US);
Scott A. Mitchell, East Haven, CT (US);
Douglas A. I. Pippin, Chester Springs, PA (US);
Peter A. Blomgren, North Branford, CT (US);
Douglas Gregory Stafford, Niskayuna, NY (US);
David R. Brittelli, Branford, CT (US);
Kevin S. Currie, North Branford, CT (US);
James W. Darrow, Wallingford, CT (US);
Jeffrey E. Kropf, Branford, CT (US);
Seung H. Lee, Branford, CT (US);
Steven L. Gallion, Wallingford, CT (US);
Scott A. Mitchell, East Haven, CT (US);
Douglas A. I. Pippin, Chester Springs, PA (US);
Peter A. Blomgren, North Branford, CT (US);
Douglas Gregory Stafford, Niskayuna, NY (US);
CGI Pharmaceuticals, Inc., Branford, CT (US);
Abstract
At least one chemical entity chosen from compounds of Formula 2 and pharmaceutically acceptable salts, solvates, chelates, non-covalent complexes, prodrugs, and mixtures thereof is described herein. Pharmaceutical compositions comprising at least one chemical entity of the invention, together with at least one pharmaceutically acceptable vehicle chosen from carriers adjuvants, and excipients, are described. Methods of treating patients suffering from certain diseases responsive to inhibition of Btk activity and/or B-cell activity are described. Methods for determining the presence of Btk in a sample are described.